Lupin Limited Secures Tentative FDA Approval for Apixaban Oral Suspension to Enhance Patient Treatment Options#FDA_Approval#Lupin_Limited#Apixaban_Oral_Suspension
Lupin Limited Secures Tentative FDA Approval for Apixaban Oral Suspension to Enhance Patient Treatment Options
Lupin Limited has announced tentative FDA approval for Apixaban Oral Suspension, providing a new administration option for patients requiring anticoagulation therapy.
third-news.com
September 28, 2026 at 1:31 PM
Lupin Limited Secures Tentative FDA Approval for Apixaban Oral Suspension to Enhance Patient Treatment Options#FDA_Approval#Lupin_Limited#Apixaban_Oral_Suspension
Lupin Introduces Topiramate Extended-Release Capsules to U.S. Market, Enhancing Treatment Options#United_States#Naples#Lupin_Limited#Topiramate#Trokendi_XR
Lupin Introduces Topiramate Extended-Release Capsules to U.S. Market, Enhancing Treatment Options
Lupin Limited has launched Topiramate Extended-Release Capsules in various dosages in the U.S., offering new treatment options for seizure disorders and migraines.
third-news.com
February 4, 2026 at 6:04 PM
Lupin Introduces Topiramate Extended-Release Capsules to U.S. Market, Enhancing Treatment Options#United_States#Naples#Lupin_Limited#Topiramate#Trokendi_XR
Lupin Receives FDA Approval for Sugammadex Injection in U.S. Market#United_States#FDA_Approval#Naples#Lupin_Limited#Sugammadex
Lupin Receives FDA Approval for Sugammadex Injection in U.S. Market
Lupin Limited announces the launch of Sugammadex Injection in the U.S. after receiving FDA approval, marking a significant advancement in its pharmaceutical offerings.
third-news.com
July 30, 2026 at 4:47 PM
Lupin Receives FDA Approval for Sugammadex Injection in U.S. Market#United_States#FDA_Approval#Naples#Lupin_Limited#Sugammadex
Lupin Limited Launches Azilsartan Medoxomil Tablets for Hypertension in U.S. Market#United_States#Hypertension#Naples#Lupin_Limited#Azilsartan
Lupin Limited Launches Azilsartan Medoxomil Tablets for Hypertension in U.S. Market
Lupin Limited has officially launched Azilsartan Medoxomil Tablets in the U.S. after FDA approval, positioning itself as a key player in hypertension treatment.
third-news.com
June 17, 2026 at 4:38 PM
Lupin Limited Launches Azilsartan Medoxomil Tablets for Hypertension in U.S. Market#United_States#Hypertension#Naples#Lupin_Limited#Azilsartan
Lupin Marks It’s Entry into the Chinese Market with New Drug Approval#China#Beijing#Lupin_Limited#Oseltamivir#Yabao_Pharmaceuticals
Lupin Marks It’s Entry into the Chinese Market with New Drug Approval
Global pharmaceutical giant Lupin Limited has secured approval from China for Oseltamivir Phosphate, marking a major milestone in expanding its market presence in the country.
third-news.com
May 22, 2026 at 11:09 AM
Lupin Marks It’s Entry into the Chinese Market with New Drug Approval#China#Beijing#Lupin_Limited#Oseltamivir#Yabao_Pharmaceuticals
Lupin Achieves FDA Approval for Modafinil Tablets Targeting Sleep Disorders#India#FDA_Approval#Mumbai#Lupin_Limited#Modafinil_Tablets
Lupin Achieves FDA Approval for Modafinil Tablets Targeting Sleep Disorders
Lupin Limited celebrates FDA approval for Modafinil Tablets, advancing treatment options for sleep disorders in the U.S. market.
third-news.com
September 4, 2026 at 5:48 PM
Lupin Achieves FDA Approval for Modafinil Tablets Targeting Sleep Disorders#India#FDA_Approval#Mumbai#Lupin_Limited#Modafinil_Tablets
Lupin and Tenpoint Therapeutics Forge Strategic Alliance to Launch YUVEZZI™ Across Europe#India#Mumbai#Lupin_Limited#YUVEZZI#Tenpoint_Therapeutics
Lupin and Tenpoint Therapeutics Forge Strategic Alliance to Launch YUVEZZI™ Across Europe
Lupin Limited and Tenpoint Therapeutics have announced a strategic partnership to market YUVEZZI™ in Europe, enhancing patient access to innovative eye care solutions.
third-news.com
August 20, 2026 at 1:36 PM
Lupin and Tenpoint Therapeutics Forge Strategic Alliance to Launch YUVEZZI™ Across Europe#India#Mumbai#Lupin_Limited#YUVEZZI#Tenpoint_Therapeutics
Lupin and Tenpoint Therapeutics Form Strategic Alliance for YUVEZZI™ Launch#India#Mumbai#Lupin_Limited#YUVEZZI#Tenpoint_Therapeutics
Lupin and Tenpoint Therapeutics Form Strategic Alliance for YUVEZZI™ Launch
Lupin Limited and Tenpoint Therapeutics have announced a strategic partnership to market YUVEZZI™ in various European regions, enhancing access to innovative presbyopia treatment.
third-news.com
August 20, 2026 at 12:33 PM
Lupin and Tenpoint Therapeutics Form Strategic Alliance for YUVEZZI™ Launch#India#Mumbai#Lupin_Limited#YUVEZZI#Tenpoint_Therapeutics
Lupin and Tenpoint Therapeutics Form Strategic Partnership for YUVEZZI™ in Europe and Beyond#None#Lupin_Limited#YUVEZZI#Tenpoint_Therapeutics
Lupin and Tenpoint Therapeutics Form Strategic Partnership for YUVEZZI™ in Europe and Beyond
Lupin Limited and Tenpoint Therapeutics have announced a strategic partnership aimed at marketing YUVEZZI™ in various European regions, enhancing access to presbyopia treatment for millions.
third-news.com
August 20, 2026 at 1:53 PM
Lupin and Tenpoint Therapeutics Form Strategic Partnership for YUVEZZI™ in Europe and Beyond#None#Lupin_Limited#YUVEZZI#Tenpoint_Therapeutics
Lupin Achieves FDA Approval for Pitolisant Tablets to Aid Narcolepsy Treatment#India#Mumbai#Narcolepsy#Lupin_Limited#Wakix
Lupin Achieves FDA Approval for Pitolisant Tablets to Aid Narcolepsy Treatment
Lupin Limited has received FDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg, providing essential treatment for narcolepsy. This milestone strengthens Lupin’s global pharmaceutical portfolio.
third-news.com
August 17, 2026 at 4:10 PM
Lupin Achieves FDA Approval for Pitolisant Tablets to Aid Narcolepsy Treatment#India#Mumbai#Narcolepsy#Lupin_Limited#Wakix
Lupin Limited Secures FDA Approval for Oral Suspension of Sodium Zirconium Cyclosilicate#United_States#FDA_Approval#Mumbai#Lupin_Limited#Sodium_Zirconium
Lupin Limited Secures FDA Approval for Oral Suspension of Sodium Zirconium Cyclosilicate
Lupin Limited has received FDA approval for Sodium Zirconium Cyclosilicate oral suspension, expanding treatment options for hyperkalemia in the U.S.
third-news.com
August 10, 2026 at 3:51 PM
Lupin Limited Secures FDA Approval for Oral Suspension of Sodium Zirconium Cyclosilicate#United_States#FDA_Approval#Mumbai#Lupin_Limited#Sodium_Zirconium
Lupin Limited Advances Oncology Strategy with Kaveri Therapeutics Partnership#India#Mumbai#Lupin_Limited#Kaveri_Therapeutics#Oncology_Programs
Lupin Limited Advances Oncology Strategy with Kaveri Therapeutics Partnership
Lupin Limited has announced the spin-out of two oncology programs to Kaveri Therapeutics, a move set to strengthen its oncology strategy and fund global trials.
third-news.com
July 21, 2026 at 5:08 AM
Lupin Limited Advances Oncology Strategy with Kaveri Therapeutics Partnership#India#Mumbai#Lupin_Limited#Kaveri_Therapeutics#Oncology_Programs
Lupin Limited Recognized as a Leader in Global Sustainability by TIME and Statista#Sustainability#India#Mumbai#Lupin_Limited#Time_Statista
Lupin Limited Recognized as a Leader in Global Sustainability by TIME and Statista
Lupin Limited has made its debut on TIME and Statista's list of the world's most sustainable companies, showcasing its commitment to environmental and social responsibility.
third-news.com
July 6, 2026 at 12:13 PM
Lupin Limited Recognized as a Leader in Global Sustainability by TIME and Statista#Sustainability#India#Mumbai#Lupin_Limited#Time_Statista
Lupin Gains Tentative FDA Approval for Enzalutamide Tablets, Expanding Treatment Options#United_States#Mumbai#Lupin_Limited#XTANDI#enzalutamide
Lupin Gains Tentative FDA Approval for Enzalutamide Tablets, Expanding Treatment Options
Lupin Limited has received tentative U.S. FDA approval for Enzalutamide Tablets in multiple strengths, enhancing patient treatment options and health outcomes.
third-news.com
June 26, 2026 at 1:38 PM
Lupin Gains Tentative FDA Approval for Enzalutamide Tablets, Expanding Treatment Options#United_States#Mumbai#Lupin_Limited#XTANDI#enzalutamide
Lupin Achieves Milestone with FDA Approval for Ranluspec™ Injection#United_States#FDA_Approval#Mumbai#Lupin_Limited#Ranluspec
Lupin Achieves Milestone with FDA Approval for Ranluspec™ Injection
Lupin Limited has announced the approval of their biosimilar Ranluspec™ by the U.S. FDA, expanding access to vision therapies for patients.
third-news.com
June 4, 2026 at 8:51 PM
Lupin Achieves Milestone with FDA Approval for Ranluspec™ Injection#United_States#FDA_Approval#Mumbai#Lupin_Limited#Ranluspec
Lupin and Natco Get FDA Approval for Eribulin Mesylate Injection Treatment#India#Mumbai#Lupin_Limited#NATCO_Pharma#Eribulin_Mesylate
Lupin and Natco Get FDA Approval for Eribulin Mesylate Injection Treatment
Lupin Limited and Natco Pharma have received FDA approval for their Eribulin Mesylate Injection. This breakthrough therapy targets tough-to-treat metastatic cancers.
third-news.com
June 3, 2026 at 7:14 AM
Lupin and Natco Get FDA Approval for Eribulin Mesylate Injection Treatment#India#Mumbai#Lupin_Limited#NATCO_Pharma#Eribulin_Mesylate
Lupin Achieves Significant Milestone with China Approval of New Oseltamivir Oral Suspension#India#Mumbai#Lupin_Limited#Oseltamivir#Yabao_Pharmaceuticals
Lupin Achieves Significant Milestone with China Approval of New Oseltamivir Oral Suspension
Lupin Limited proudly announces their first entry into the Chinese pharmaceutical market with the approval of oseltamivir oral suspension, enhancing pediatric care access.
third-news.com
May 23, 2026 at 1:22 AM
Lupin Achieves Significant Milestone with China Approval of New Oseltamivir Oral Suspension#India#Mumbai#Lupin_Limited#Oseltamivir#Yabao_Pharmaceuticals
Lupin Expands Its Market Reach with Approval in China for Oseltamivir Phosphate Suspension#China#Beijing#Lupin_Limited#Oseltamivir#Yabao_Pharmaceuticals
Lupin Expands Its Market Reach with Approval in China for Oseltamivir Phosphate Suspension
Lupin Limited has gained approval for its Oseltamivir phosphate suspension in China, marking a significant step in its global expansion strategy, particularly for pediatric care.
third-news.com
May 23, 2026 at 1:22 AM
Lupin Expands Its Market Reach with Approval in China for Oseltamivir Phosphate Suspension#China#Beijing#Lupin_Limited#Oseltamivir#Yabao_Pharmaceuticals
Lupin Limited Achieves Major Milestone with Approval of Oseltamivir in China#India#Mumbai#Lupin_Limited#Yabao_Pharmaceuticals#Oseltamivir_Phosphate
Lupin Limited Achieves Major Milestone with Approval of Oseltamivir in China
Lupin Limited proudly announces the approval of Oseltamivir Phosphate in China, marking a significant entry into the Chinese pharmaceutical market.
third-news.com
May 22, 2026 at 4:24 PM
Lupin Limited Achieves Major Milestone with Approval of Oseltamivir in China#India#Mumbai#Lupin_Limited#Yabao_Pharmaceuticals#Oseltamivir_Phosphate
Lupin Limited Launches Oseltamivir Phosphate Oral Suspension in China, Expanding Global Reach#China#Beijing#Lupin_Limited#Yabao_Pharmaceuticals#Oseltamivir_Phosphate
Lupin Limited Launches Oseltamivir Phosphate Oral Suspension in China, Expanding Global Reach
Lupin Limited proudly announces the approval of an oral suspension of oseltamivir phosphate in China, marking a key milestone in its global expansion efforts.
third-news.com
May 22, 2026 at 2:16 PM
Lupin Limited Launches Oseltamivir Phosphate Oral Suspension in China, Expanding Global Reach#China#Beijing#Lupin_Limited#Yabao_Pharmaceuticals#Oseltamivir_Phosphate
Lupin's Approval for Oseltamivir Phosphate Marks Major Milestone in China#None#Lupin_Limited#Oseltamivir#Yabao_Pharmaceuticals
Lupin's Approval for Oseltamivir Phosphate Marks Major Milestone in China
Lupin Limited secures approval for Oseltamivir Phosphate Oral Suspension in China, marking a strategic entry into a significant market alongside Yabao Pharmaceuticals.
third-news.com
May 22, 2026 at 11:17 AM
Lupin's Approval for Oseltamivir Phosphate Marks Major Milestone in China#None#Lupin_Limited#Oseltamivir#Yabao_Pharmaceuticals
Lupin Gets FDA Tentative Approval for Revefenacin Inhalation Solution for COPD#India#Mumbai#Lupin_Limited#Yupelri_COPD#Revefenacin_Inhalation
Lupin Gets FDA Tentative Approval for Revefenacin Inhalation Solution for COPD
Lupin Limited has received tentative approval from the U.S. FDA for their Revefenacin Inhalation Solution, targeting COPD patients. A significant step for the pharmaceutical giant.
third-news.com
May 18, 2026 at 6:09 PM
Lupin Gets FDA Tentative Approval for Revefenacin Inhalation Solution for COPD#India#Mumbai#Lupin_Limited#Yupelri_COPD#Revefenacin_Inhalation
Lupin Limited Secures FDA Green Light for Famotidine Injection, Enhancing Treatment Options#India#FDA_Approval#Mumbai#Lupin_Limited#Famotidine_Injection
Lupin Limited Secures FDA Green Light for Famotidine Injection, Enhancing Treatment Options
Lupin Limited has announced FDA approval for its Famotidine Injection, broadening treatment options for patients with specific gastrointestinal conditions.
third-news.com
May 14, 2026 at 1:33 AM
Lupin Limited Secures FDA Green Light for Famotidine Injection, Enhancing Treatment Options#India#FDA_Approval#Mumbai#Lupin_Limited#Famotidine_Injection
Lupin Limited Gains FDA Approval for New Glycerol Medication, Enhancing Urea Cycle Disorder Treatments#United_States#FDA_Approval#Mumbai#Lupin_Limited#glycerol_phenylbutyrate
Lupin Limited Gains FDA Approval for New Glycerol Medication, Enhancing Urea Cycle Disorder Treatments
Lupin Limited announces FDA approval for its Glycerol Phenylbutyrate Oral Liquid, a vital addition for managing urea cycle disorders. The new medication promises significant patient health benefits.
third-news.com
May 5, 2026 at 6:22 PM
Lupin Limited Gains FDA Approval for New Glycerol Medication, Enhancing Urea Cycle Disorder Treatments#United_States#FDA_Approval#Mumbai#Lupin_Limited#glycerol_phenylbutyrate
Lupin Receives FDA Approval for Dapagliflozin and Metformin Hydrochloride Tablets#United_States#Mumbai#Lupin_Limited#Metformin#Dapagliflozin
Lupin Receives FDA Approval for Dapagliflozin and Metformin Hydrochloride Tablets
Lupin Limited has received FDA approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, expanding its pharmaceutical offerings.
third-news.com
April 8, 2026 at 2:19 PM
Lupin Receives FDA Approval for Dapagliflozin and Metformin Hydrochloride Tablets#United_States#Mumbai#Lupin_Limited#Metformin#Dapagliflozin